Andrée Delahaye-Duriez
Andrée Delahaye-Duriez
Université Sorbonne Paris Nord / AP-HP
Verified email at
Cited by
Cited by
Machine learning applications in drug development
C Réda, E Kaufmann, A Delahaye-Duriez
Computational and Structural Biotechnology Journal 18, 241-252, 2020
Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease
MR Johnson, K Shkura, SR Langley, A Delahaye-Duriez, P Srivastava, ...
Nature Neuroscience, 2015
The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever
D Tchernitchko, M Legendre, C Cazeneuve, A Delahaye, F Niel, ...
Human mutation 22 (4), 339-340, 2003
Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia
N Chassaing, A Causse, A Vigouroux, A Delahaye, JL Alessandri, ...
Clinical genetics 86 (4), 326-334, 2014
Haploinsufficiency of SOX5 at 12p12. 1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features
AN Lamb, JA Rosenfeld, NJ Neill, ME Talkowski, I Blumenthal, S Girirajan, ...
Human Mutation 33 (4), 728-740, 2012
Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brain
J Van Steenwinckel, AL Schang, ML Krishnan, V Degos, ...
Brain 142 (12), 3806-3833, 2019
Familial CHARGE syndrome because of CHD7 mutation: clinical intra‐and interfamilial variability
A Delahaye, Y Sznajer, S Lyonnet, M Elmaleh‐Bergès, I Delpierre, ...
Clinical genetics 72 (2), 112-121, 2007
Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery
A Delahaye-Duriez, P Srivastava, K Shkura, SR Langley, L Laaniste, ...
Genome biology 17, 1-18, 2016
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
PK Srivastava, J van Eyll, P Godard, M Mazzuferi, A Delahaye-Duriez, ...
Nature communications 9 (1), 3561, 2018
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
PK Srivastava, J van Eyll, P Godard, M Mazzuferi, A Delahaye-Duriez, ...
Nature communications 9 (1), 3561, 2018
Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11
A Goldenberg, F Riccardi, A Tessier, R Pfundt, T Busa, P Cacciagli, ...
American Journal of Medical Genetics Part A 170 (11), 2847-2859, 2016
WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation
C Mignot, L Lambert, L Pasquier, T Bienvenu, A Delahaye-Duriez, ...
Journal of medical genetics 52 (1), 61-70, 2015
Genome-wide analysis of differential RNA editing in epilepsy
PK Srivastava, M Bagnati, A Delahaye-Duriez, JH Ko, M Rotival, ...
Genome Research 27 (3), 440-450, 2017
Recurrent mutations in the CDKL5 gene: Genotype–phenotype relationships
N Bahi‐Buisson, N Villeneuve, E Caietta, A Jacquette, H Maurey, ...
American Journal of Medical Genetics Part A 158 (7), 1612-1619, 2012
MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients
D Tchernitchko, S Moutereau, M Legendre, A Delahaye, C Cazeneuve, ...
Arthritis & Rheumatism 52 (11), 3603-3605, 2005
Chromosome 22q13. 3 deletion syndrome with a de novo interstitial 22q13. 3 cryptic deletion disrupting SHANK3
A Delahaye, A Toutain, A Aboura, C Dupont, AC Tabet, B Benzacken, ...
European journal of medical genetics 52 (5), 328-332, 2009
Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series
S Jaillard, S Drunat, C Bendavid, A Aboura, A Etcheverry, H Journel, ...
European journal of medical genetics 53 (2), 66-75, 2010
16p13. 11 microduplication in 45 new patients: refined clinical significance and genotype–phenotype correlations
LA El Khattabi, S Heide, JH Caberg, J Andrieux, MD Fenzy, ...
Journal of Medical Genetics 57 (5), 301-307, 2020
2q23. 1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
S Jaillard, C Dubourg, M Gérard-Blanluet, A Delahaye, L Pasquier, ...
Journal of medical genetics 46 (12), 847-855, 2009
Further delineation of the 17p13. 3 microdeletion involving YWHAE but distal to PAFAH1B1: four additional patients
M Schiff, A Delahaye, J Andrieux, D Sanlaville, C Vincent-Delorme, ...
European journal of medical genetics 53 (5), 303-308, 2010
The system can't perform the operation now. Try again later.
Articles 1–20